Trial reportEuropean journal of nutrition2026
Immune modulation in response to coffee intake: a pilot study.
Trial report in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCoffee consumption has been associated with various health benefits; however, the underlying biological mechanisms remain poorly understood. In particular, the acute effects of coffee on circulating cytokines and the specific role of caffeine compared with the whole coffee matrix are still insufficiently characterised in humans. To our knowledge, no previous human study has directly compared immune modulation by coffee versus caffeine alone. We therefore aimed to elucidate the effect of a usual caffeine dose of 130 mg on postprandial cytokine secretion, and whether responses differ between coffee and pure caffeine.
methodsIn a randomized pilot trial, ten healthy volunteers completed three test days receiving either a coffee brew, an aqueous caffeine solution (each 130 mg caffeine/100 ml), or water. Quantitative analysis of caffeine was performed with UHPLC-MS/MS, immune markers were measured by a multiplex immunoassay.
resultsOur study demonstrates that both caffeine and coffee consumption influence the immune homeostasis, albeit with notable differences on cytokine secretion. Pure caffeine induced a higher anti-inflammatory response, as evidenced by the significant decrease in pro-inflammatory cytokines such as IL-17 A, IL-12p70, and IL-2 compared to coffee and water. The integrated response on the immune system is exemplified by the decrease of the pro-inflammatory IFN-γ (0.649 ± 0.068) and the anti-inflammatory IL-10 (0.478 ± 0.043), vs. baseline, respectively.
conclusionThese findings provide novel in vivo evidence that usual coffee and caffeine acutely affects cytokine responses differently in healthy individuals. In conclusion, our study addresses an important gap regarding the immune properties of coffee and suggests that bioactive compounds beyond caffeine contribute substantially to its immunological effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.